Search

Mark L. Berch

Examiner (ID: 5665)

Most Active Art Unit
1202
Art Unit(s)
1622, 1202, 2899, 1614, 1802, 1611, 1624
Total Applications
3573
Issued Applications
2301
Pending Applications
170
Abandoned Applications
1103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7128076 [patent_doc_number] => 20050059820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Method for manufacture of ceftriaxone sodium' [patent_app_type] => utility [patent_app_number] => 10/671298 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14936 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059820.pdf [firstpage_image] =>[orig_patent_app_number] => 10671298 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/671298
Method for manufacture of ceftriaxone sodium Sep 24, 2003 Abandoned
Array ( [id] => 7455466 [patent_doc_number] => 20040068111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Unsaturated phosphonate derivatives of purines and pyrimidines' [patent_app_type] => new [patent_app_number] => 10/663414 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9109 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20040068111.pdf [firstpage_image] =>[orig_patent_app_number] => 10663414 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/663414
Unsaturated phosphonate derivatives of purines and pyrimidines Sep 15, 2003 Abandoned
Array ( [id] => 7209116 [patent_doc_number] => 20040087787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds' [patent_app_type] => new [patent_app_number] => 10/250655 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087787.pdf [firstpage_image] =>[orig_patent_app_number] => 10250655 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/250655
Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds Sep 11, 2003 Abandoned
Array ( [id] => 7128074 [patent_doc_number] => 20050059818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Polymorph of a pharmaceutical' [patent_app_type] => utility [patent_app_number] => 10/661148 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5860 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059818.pdf [firstpage_image] =>[orig_patent_app_number] => 10661148 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/661148
Polymorph of a pharmaceutical Sep 11, 2003 Abandoned
Array ( [id] => 7336976 [patent_doc_number] => 20040132707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Catecholate beta-lactam conjugates, method for producing the same and the use thereof' [patent_app_type] => new [patent_app_number] => 10/651251 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7903 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132707.pdf [firstpage_image] =>[orig_patent_app_number] => 10651251 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651251
Catecholate beta-lactam conjugates, method for producing the same and the use thereof Aug 28, 2003 Abandoned
Array ( [id] => 7474787 [patent_doc_number] => 20040097528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Crystalline solid famciclovir forms I, II, III and preparation thereof' [patent_app_type] => new [patent_app_number] => 10/649399 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4854 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097528.pdf [firstpage_image] =>[orig_patent_app_number] => 10649399 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/649399
Crystalline solid famciclovir forms I, II, III and preparation thereof Aug 25, 2003 Abandoned
Array ( [id] => 6978785 [patent_doc_number] => 20050288503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 10/525478 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18774 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288503.pdf [firstpage_image] =>[orig_patent_app_number] => 10525478 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/525478
Novel compounds Aug 25, 2003 Abandoned
Array ( [id] => 7290999 [patent_doc_number] => 20040110740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Beta-lactamase inhibitor prodrug' [patent_app_type] => new [patent_app_number] => 10/648408 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110740.pdf [firstpage_image] =>[orig_patent_app_number] => 10648408 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/648408
Beta-lactamase inhibitor prodrug Aug 24, 2003 Issued
Array ( [id] => 7355520 [patent_doc_number] => 20040048865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Antagonists of chemokine receptors' [patent_app_type] => new [patent_app_number] => 10/648677 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12583 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048865.pdf [firstpage_image] =>[orig_patent_app_number] => 10648677 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/648677
Antagonists of chemokine receptors Aug 24, 2003 Issued
Array ( [id] => 7238260 [patent_doc_number] => 20050080090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Naphthalene derivatives' [patent_app_type] => utility [patent_app_number] => 10/645121 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32150 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080090.pdf [firstpage_image] =>[orig_patent_app_number] => 10645121 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/645121
Naphthalene derivatives Aug 20, 2003 Abandoned
Array ( [id] => 7453764 [patent_doc_number] => 20040067966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Adenosine receptor antagonists and methods of making and using the same' [patent_app_type] => new [patent_app_number] => 10/646454 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 36275 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067966.pdf [firstpage_image] =>[orig_patent_app_number] => 10646454 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/646454
Adenosine receptor antagonists and methods of making and using the same Aug 20, 2003 Abandoned
Array ( [id] => 7281350 [patent_doc_number] => 20040063727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => '6-Substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents' [patent_app_type] => new [patent_app_number] => 10/640154 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31596 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063727.pdf [firstpage_image] =>[orig_patent_app_number] => 10640154 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/640154
6-Substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents Aug 12, 2003 Abandoned
Array ( [id] => 7474607 [patent_doc_number] => 20040097510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => '8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => new [patent_app_number] => 10/639036 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53024 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097510.pdf [firstpage_image] =>[orig_patent_app_number] => 10639036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/639036
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Aug 11, 2003 Issued
Array ( [id] => 5821273 [patent_doc_number] => 20060025586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Cefdinir intermediate' [patent_app_type] => utility [patent_app_number] => 10/524397 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4999 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025586.pdf [firstpage_image] =>[orig_patent_app_number] => 10524397 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524397
Cefdinir intermediate Aug 11, 2003 Issued
Array ( [id] => 5041228 [patent_doc_number] => 20070093510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Phosphodiesterase 4 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/636979 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26008 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093510.pdf [firstpage_image] =>[orig_patent_app_number] => 10636979 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636979
Phosphodiesterase 4 inhibitors Aug 7, 2003 Issued
Array ( [id] => 7469644 [patent_doc_number] => 20040102460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Phosphodiesterase 4 inhibitors' [patent_app_type] => new [patent_app_number] => 10/636996 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19753 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102460.pdf [firstpage_image] =>[orig_patent_app_number] => 10636996 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636996
Phosphodiesterase 4 inhibitors Aug 7, 2003 Issued
Array ( [id] => 348889 [patent_doc_number] => 07495005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Xanthine derivatives, their preparation and their use in pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/636088 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11508 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495005.pdf [firstpage_image] =>[orig_patent_app_number] => 10636088 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/636088
Xanthine derivatives, their preparation and their use in pharmaceutical compositions Aug 6, 2003 Issued
Array ( [id] => 7475138 [patent_doc_number] => 20040122228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'New purine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => new [patent_app_number] => 10/634047 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23859 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122228.pdf [firstpage_image] =>[orig_patent_app_number] => 10634047 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/634047
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions Aug 3, 2003 Issued
Array ( [id] => 990928 [patent_doc_number] => 06919455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof' [patent_app_type] => utility [patent_app_number] => 10/631795 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5675 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919455.pdf [firstpage_image] =>[orig_patent_app_number] => 10631795 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/631795
Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof Jul 31, 2003 Issued
Array ( [id] => 7386828 [patent_doc_number] => 20040029835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Camptothecin analogs and methods of preparation thereof' [patent_app_type] => new [patent_app_number] => 10/629432 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16685 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029835.pdf [firstpage_image] =>[orig_patent_app_number] => 10629432 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/629432
Camptothecin analogs and methods of preparation thereof Jul 28, 2003 Issued
Menu